Sign inGet started

EIDX

Eidos Therapeutics, Inc.CIK 1731831 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15

AI insights for EIDX PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for EIDX
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Turtle CameronChief Business Officer59$0$8.21M2021-01-26
BridgeBio Pharma, Inc.10% Owner22$116.23M$1.64M2021-01-26
Sinha UmaChief Scientific Officer33$0$3.50M2021-01-26
Valle FrancoSenior Vice President, Finance28$0$1.82M2021-01-26
Fox Jonathan CSee Remarks45$0$7.28M2021-01-26
Satvat Ali J.Director, 10% Owner15$72.01M$02021-01-26
Lis WilliamDirector6$0$02021-01-26
Hooper Suzanne SawochkaDirector4$0$02021-01-26
Rohlen DouglasDirector4$0$02021-01-26
Shah Rajeev M.Director6$18.00M$02020-05-27
AGUIAR ERICDirector, 10% Owner5$55.01M$02020-05-27
Siu ChristineSee Remarks40$0$4.77M2019-12-09
Kumar NeilChief Executive Officer9$72.01M$02019-07-03
Huh HoyoungDirector1$0$02018-06-22
RA Capital Healthcare Fund LP10% Owner3$18.00M$02018-06-22

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Sinha UmaChief Scientific Officer D To issuer deriv2021-01-262021-01-2860,000— $00SEC↗
Hooper Suzanne SawochkaDirector D To issuer deriv2021-01-262021-01-2821,447— $00SEC↗
Hooper Suzanne SawochkaDirector D To issuer deriv2021-01-262021-01-284,526— $00SEC↗
Lis WilliamDirector D To issuer deriv2021-01-262021-01-2843,056— $00SEC↗
Lis WilliamDirector D To issuer deriv2021-01-262021-01-2821,528— $00SEC↗
Lis WilliamDirector D To issuer deriv2021-01-262021-01-2821,528— $00SEC↗
Satvat Ali J.Director D To issuer deriv2021-01-262021-01-2821,528— $00SEC↗
Satvat Ali J.Director D To issuer deriv2021-01-262021-01-2821,528— $00SEC↗
Satvat Ali J.Director D To issuer deriv2021-01-262021-01-2843,056— $00SEC↗
Turtle CameronChief Business Officer D To issuer deriv2021-01-262021-01-2853,157— $00SEC↗
Turtle CameronChief Business Officer D To issuer deriv2021-01-262021-01-289,469— $00SEC↗
Valle FrancoSenior Vice President, Finan D To issuer deriv2021-01-262021-01-2824,350— $00SEC↗
Rohlen DouglasDirector D To issuer deriv2021-01-262021-01-2821,447— $00SEC↗
Rohlen DouglasDirector D To issuer deriv2021-01-262021-01-284,526— $00SEC↗
Fox Jonathan CSee Remarks D To issuer deriv2021-01-262021-01-2870,000— $00SEC↗
BridgeBio Pharma, Inc.10% Owner P Buy2021-01-262021-01-2614,428,836— $01,000SEC↗
Sinha UmaChief Scientific Officer U Tender2021-01-262021-01-28303,525— $00SEC↗
Turtle CameronChief Business Officer U Tender2021-01-262021-01-2850,699— $00SEC↗
Fox Jonathan CSee Remarks U Tender2021-01-262021-01-28380,467— $00SEC↗
Sinha UmaChief Scientific Officer S Sale2021-01-132021-01-154,934$124.72 $615.4K308,825SEC↗
Sinha UmaChief Scientific Officer S Sale2021-01-132021-01-15696$121.11 $84.3K315,829SEC↗
Sinha UmaChief Scientific Officer S Sale2021-01-132021-01-15572$122.27 $69.9K315,257SEC↗
Sinha UmaChief Scientific Officer S Sale2021-01-132021-01-151,498$123.48 $185.0K313,759SEC↗
Sinha UmaChief Scientific Officer S Sale2021-01-132021-01-152,000$125.35 $250.7K306,825SEC↗
Sinha UmaChief Scientific Officer S Sale2021-01-132021-01-15300$126.39 $37.9K306,525SEC↗
Valle FrancoSenior Vice President, Finan M Exercise deriv2021-01-122021-01-131,747— $024,350SEC↗
Valle FrancoSenior Vice President, Finan M Exercise2021-01-122021-01-131,747$7.24 $12.6K1,747SEC↗
Valle FrancoSenior Vice President, Finan S Sale2021-01-122021-01-131,747$125.45 $219.2K0SEC↗
Valle FrancoSenior Vice President, Finan M Exercise deriv2021-01-112021-01-131,500— $026,097SEC↗
Valle FrancoSenior Vice President, Finan S Sale2021-01-112021-01-131,500$125.61 $188.4K0SEC↗
Valle FrancoSenior Vice President, Finan M Exercise2021-01-112021-01-131,500$7.24 $10.9K1,500SEC↗
Fox Jonathan CSee Remarks G Gift2020-12-282021-01-28500— $0380,467SEC↗
Turtle CameronChief Business Officer M Exercise deriv2020-12-152020-12-1621,843— $053,157SEC↗
Turtle CameronChief Business Officer M Exercise deriv2020-12-152020-12-164,451— $09,469SEC↗
Turtle CameronChief Business Officer S Sale2020-12-152020-12-163,756$110.29 $414.2K73,159SEC↗
Turtle CameronChief Business Officer S Sale2020-12-152020-12-1611,445$112.19 $1.28M54,114SEC↗
Turtle CameronChief Business Officer S Sale2020-12-152020-12-167,600$111.31 $846.0K65,559SEC↗
Turtle CameronChief Business Officer S Sale2020-12-152020-12-163,493$112.97 $394.6K50,621SEC↗
Turtle CameronChief Business Officer M Exercise2020-12-152020-12-1621,843$13.20 $288.3K76,915SEC↗
Turtle CameronChief Business Officer M Exercise2020-12-152020-12-164,451$17.00 $75.7K55,072SEC↗
Sinha UmaChief Scientific Officer S Sale2020-12-022020-12-04702$90.63 $63.6K317,025SEC↗
Sinha UmaChief Scientific Officer S Sale2020-12-022020-12-04300$91.89 $27.6K316,725SEC↗
Sinha UmaChief Scientific Officer S Sale2020-12-022020-12-04200$92.97 $18.6K316,525SEC↗
Sinha UmaChief Scientific Officer S Sale2020-12-022020-12-043,798$89.63 $340.4K317,727SEC↗
Turtle CameronChief Business Officer G Gift2020-11-112020-11-131,500— $050,621SEC↗
Turtle CameronChief Business Officer S Sale2020-11-112020-11-13908$75.23 $68.3K52,121SEC↗
Turtle CameronChief Business Officer S Sale2020-11-112020-11-139,497$74.75 $709.9K53,029SEC↗
Turtle CameronChief Business Officer S Sale2020-11-112020-11-133,005$73.56 $221.0K62,526SEC↗
Valle FrancoSenior Vice President, Finan M Exercise deriv2020-11-092020-11-101,623— $027,597SEC↗
Valle FrancoSenior Vice President, Finan S Sale2020-11-092020-11-101,623$74.93 $121.6K0SEC↗
Valle FrancoSenior Vice President, Finan M Exercise2020-11-092020-11-101,623$7.24 $11.8K1,623SEC↗
Turtle CameronChief Business Officer M Exercise deriv2020-11-022020-11-035,000— $075,000SEC↗
Turtle CameronChief Business Officer M Exercise deriv2020-11-022020-11-032,500— $013,920SEC↗
Turtle CameronChief Business Officer M Exercise2020-11-022020-11-032,500$17.00 $42.5K78,031SEC↗
Turtle CameronChief Business Officer M Exercise2020-11-022020-11-035,000$13.20 $66.0K75,531SEC↗
Turtle CameronChief Business Officer S Sale2020-11-022020-11-033,146$71.42 $224.7K65,740SEC↗
Turtle CameronChief Business Officer S Sale2020-11-022020-11-03209$72.10 $15.1K65,531SEC↗
Turtle CameronChief Business Officer S Sale2020-11-022020-11-039,145$70.44 $644.2K68,886SEC↗
Sinha UmaChief Scientific Officer S Sale2020-10-292020-10-303,700$72.60 $268.6K321,525SEC↗
Sinha UmaChief Scientific Officer S Sale2020-10-292020-10-301,300$71.90 $93.5K325,225SEC↗
Sinha UmaChief Scientific Officer G Gift2020-10-272021-01-283,000— $0303,525SEC↗
Valle FrancoSenior Vice President, Finan M Exercise deriv2020-10-082020-10-095,199— $029,220SEC↗
Valle FrancoSenior Vice President, Finan M Exercise2020-10-082020-10-095,199$7.24 $37.6K5,199SEC↗
Valle FrancoSenior Vice President, Finan S Sale2020-10-082020-10-095,199$74.85 $389.1K0SEC↗
Valle FrancoSenior Vice President, Finan M Exercise deriv2020-10-072020-10-095,000— $034,419SEC↗
Valle FrancoSenior Vice President, Finan M Exercise2020-10-072020-10-095,000$7.24 $36.2K5,444SEC↗
Valle FrancoSenior Vice President, Finan S Sale2020-10-072020-10-095,444$75.08 $408.7K0SEC↗
Sinha UmaChief Scientific Officer S Sale2020-10-012020-10-024,831$52.35 $252.9K326,525SEC↗
Sinha UmaChief Scientific Officer S Sale2020-09-302020-10-02100$52.00 $5.2K331,356SEC↗
Sinha UmaChief Scientific Officer S Sale2020-09-302020-10-0269$52.08 $3.6K331,456SEC↗
Fox Jonathan CSee Remarks S Sale2020-09-172020-09-185,767$50.16 $289.3K377,673SEC↗
Fox Jonathan CSee Remarks S Sale2020-09-162020-09-163,122$50.16 $156.6K383,440SEC↗
Fox Jonathan CSee Remarks S Sale2020-09-152020-09-161,000$50.06 $50.1K386,562SEC↗
Fox Jonathan CSee Remarks S Sale2020-09-142020-09-16111$50.00 $5.5K387,562SEC↗
Turtle CameronChief Business Officer M Exercise deriv2020-09-102020-09-112,500— $016,420SEC↗
Turtle CameronChief Business Officer S Sale2020-09-102020-09-112,500$47.00 $117.5K70,531SEC↗
Turtle CameronChief Business Officer M Exercise2020-09-102020-09-112,500$17.00 $42.5K73,031SEC↗
Rohlen DouglasDirector A Award deriv2020-08-062020-08-104,526— $04,526SEC↗
Rohlen DouglasDirector A Award deriv2020-08-062020-08-1021,447— $021,447SEC↗
Hooper Suzanne SawochkaDirector A Award deriv2020-08-062020-08-1021,447— $021,447SEC↗
Hooper Suzanne SawochkaDirector A Award deriv2020-08-062020-08-104,526— $04,526SEC↗
Turtle CameronChief Business Officer M Exercise deriv2020-08-032020-08-055,000— $080,000SEC↗
Turtle CameronChief Business Officer S Sale2020-08-032020-08-056,700$40.25 $269.7K71,031SEC↗
Turtle CameronChief Business Officer M Exercise2020-08-032020-08-055,000$13.20 $66.0K80,531SEC↗
Turtle CameronChief Business Officer S Sale2020-08-032020-08-052,800$39.05 $109.3K77,731SEC↗
Turtle CameronChief Business Officer S Sale2020-08-032020-08-05500$40.89 $20.4K70,531SEC↗
Fox Jonathan CSee Remarks S Sale2020-07-072020-07-095,000$50.00 $250.0K387,673SEC↗
Fox Jonathan CSee Remarks J Other2020-06-292020-07-011,088— $0392,673SEC↗
Fox Jonathan CSee Remarks S Sale2020-06-032020-06-055,000$50.00 $250.0K391,585SEC↗
Fox Jonathan CSee Remarks G Gift2020-06-022020-06-051,020— $0396,585SEC↗
Fox Jonathan CSee Remarks G Gift2020-06-012020-06-051,020— $0397,605SEC↗
Sinha UmaChief Scientific Officer A Award2020-05-312020-06-05444$41.57 $18.5K331,525SEC↗
Valle FrancoSenior Vice President, Finan A Award2020-05-312020-06-05444$41.57 $18.5K444SEC↗
Fox Jonathan CSee Remarks A Award2020-05-312020-06-05444$41.57 $18.5K3,294SEC↗
Turtle CameronChief Business Officer A Award2020-05-312020-06-05376$41.57 $15.6K75,531SEC↗
Fox Jonathan CSee Remarks S Sale2020-05-282020-06-015,000$50.00 $250.0K398,625SEC↗
Lis WilliamDirector A Award deriv2020-05-272020-05-2921,528— $021,528SEC↗
Satvat Ali J.Director, 10% Owner A Award deriv2020-05-272020-05-2921,528— $021,528SEC↗
Shah Rajeev M.Director A Award deriv2020-05-272020-05-2921,528— $021,528SEC↗
AGUIAR ERICDirector A Award deriv2020-05-272020-05-2921,528— $021,528SEC↗
Turtle CameronChief Business Officer M Exercise deriv2020-05-262020-05-282,500— $018,920SEC↗
Turtle CameronChief Business Officer S Sale2020-05-262020-05-282,500$47.00 $117.5K75,155SEC↗
Turtle CameronChief Business Officer M Exercise2020-05-262020-05-282,500$17.00 $42.5K77,655SEC↗
Turtle CameronChief Business Officer M Exercise deriv2020-05-012020-05-055,000— $085,000SEC↗
Turtle CameronChief Business Officer M Exercise2020-05-012020-05-055,000$13.20 $66.0K85,155SEC↗
Turtle CameronChief Business Officer S Sale2020-05-012020-05-057,750$40.52 $314.0K77,405SEC↗
Turtle CameronChief Business Officer S Sale2020-05-012020-05-051,050$41.23 $43.3K76,355SEC↗
Turtle CameronChief Business Officer S Sale2020-05-012020-05-051,180$42.56 $50.2K75,175SEC↗
Turtle CameronChief Business Officer S Sale2020-05-012020-05-0520$43.26 $86575,155SEC↗
Fox Jonathan CSee Remarks S Sale2020-04-242020-04-272,153$50.00 $107.7K403,625SEC↗
Fox Jonathan CSee Remarks S Sale2020-04-232020-04-272,847$50.00 $142.3K405,778SEC↗
Valle FrancoSenior Vice President, Finan M Exercise deriv2020-04-202020-04-222,000— $039,419SEC↗
Valle FrancoSenior Vice President, Finan S Sale2020-04-202020-04-222,000$49.79 $99.6K0SEC↗
Valle FrancoSenior Vice President, Finan M Exercise2020-04-202020-04-222,000$7.24 $14.5K2,000SEC↗
Valle FrancoSenior Vice President, Finan M Exercise deriv2020-03-262020-03-305,000— $041,419SEC↗
Valle FrancoSenior Vice President, Finan M Exercise2020-03-262020-03-305,000$7.24 $36.2K5,000SEC↗
Valle FrancoSenior Vice President, Finan S Sale2020-03-262020-03-303,000$47.87 $143.6K2,000SEC↗
Valle FrancoSenior Vice President, Finan S Sale2020-03-262020-03-302,000$48.85 $97.7K0SEC↗
Valle FrancoSenior Vice President, Finan M Exercise deriv2020-03-022020-03-043,000— $046,419SEC↗
Fox Jonathan CSee Remarks S Sale2020-03-022020-03-0410,000$51.57 $515.7K408,625SEC↗
Valle FrancoSenior Vice President, Finan M Exercise2020-03-022020-03-043,000$7.24 $21.7K3,000SEC↗
Valle FrancoSenior Vice President, Finan S Sale2020-03-022020-03-041,000$53.06 $53.1K0SEC↗
Valle FrancoSenior Vice President, Finan S Sale2020-03-022020-03-042,000$51.96 $103.9K1,000SEC↗
Fox Jonathan CSee Remarks S Sale2020-02-132020-02-1910,000$54.00 $540.0K418,625SEC↗
Fox Jonathan CSee Remarks G Gift2020-02-042020-02-191,632— $0428,625SEC↗
Turtle CameronChief Business Officer M Exercise deriv2020-02-032020-02-055,000— $090,000SEC↗
Turtle CameronChief Business Officer M Exercise deriv2020-02-032020-02-052,500— $021,420SEC↗
Turtle CameronChief Business Officer S Sale2020-02-032020-02-055,289$53.32 $282.0K87,366SEC↗
Turtle CameronChief Business Officer S Sale2020-02-032020-02-057,211$53.89 $388.6K80,155SEC↗
Turtle CameronChief Business Officer M Exercise2020-02-032020-02-052,500$17.00 $42.5K92,655SEC↗
Turtle CameronChief Business Officer M Exercise2020-02-032020-02-055,000$13.20 $66.0K90,155SEC↗
Fox Jonathan CSee Remarks S Sale2020-01-152020-01-163,580$55.00 $196.9K430,257SEC↗
Fox Jonathan CSee Remarks S Sale2020-01-142020-01-166,420$55.01 $353.2K433,837SEC↗
Fox Jonathan CSee Remarks G Gift2019-12-302020-01-09100— $0440,257SEC↗
Fox Jonathan CSee Remarks G Gift2019-12-262020-01-09170— $0440,357SEC↗
Sinha UmaChief Scientific Officer S Sale2019-12-182019-12-201,702$63.31 $107.8K331,081SEC↗
Sinha UmaChief Scientific Officer S Sale2019-12-182019-12-20825$62.49 $51.6K332,783SEC↗
Sinha UmaChief Scientific Officer S Sale2019-12-182019-12-209,973$61.61 $614.4K333,608SEC↗
Siu ChristineCFO and Secretary M Exercise deriv2019-12-092019-12-1110,000— $0152,191SEC↗
Siu ChristineCFO and Secretary S Sale2019-12-092019-12-11901$60.05 $54.1K36,470SEC↗
Siu ChristineCFO and Secretary S Sale2019-12-092019-12-119,099$59.62 $542.5K37,371SEC↗
Siu ChristineCFO and Secretary M Exercise2019-12-092019-12-1110,000$0.59 $5.9K46,470SEC↗
Turtle CameronChief Business Officer M Exercise deriv2019-12-062019-12-1010,000— $095,000SEC↗
Turtle CameronChief Business Officer S Sale2019-12-062019-12-108,900$59.43 $528.9K85,155SEC↗
Turtle CameronChief Business Officer S Sale2019-12-062019-12-10400$56.84 $22.7K94,755SEC↗
Turtle CameronChief Business Officer M Exercise2019-12-062019-12-1010,000$13.20 $132.0K95,155SEC↗
Turtle CameronChief Business Officer S Sale2019-12-062019-12-10700$58.28 $40.8K94,055SEC↗
Siu ChristineCFO and Secretary M Exercise deriv2019-12-042019-12-0510,000— $0162,191SEC↗
Siu ChristineCFO and Secretary S Sale2019-12-042019-12-058,800$58.60 $515.7K37,670SEC↗
Siu ChristineCFO and Secretary M Exercise2019-12-042019-12-0510,000$0.59 $5.9K46,470SEC↗
Siu ChristineCFO and Secretary S Sale2019-12-042019-12-051,200$59.39 $71.3K36,470SEC↗
Fox Jonathan CSee Remarks S Sale2019-12-042019-12-0510,000$58.90 $589.0K440,527SEC↗
Siu ChristineCFO and Secretary M Exercise deriv2019-12-032019-12-0510,000— $0172,191SEC↗
Siu ChristineCFO and Secretary S Sale2019-12-032019-12-054,000$59.65 $238.6K36,470SEC↗
Siu ChristineCFO and Secretary S Sale2019-12-032019-12-055,400$58.95 $318.3K40,470SEC↗
Siu ChristineCFO and Secretary S Sale2019-12-032019-12-05600$57.82 $34.7K45,870SEC↗
Siu ChristineCFO and Secretary M Exercise2019-12-032019-12-0510,000$0.59 $5.9K46,470SEC↗
Fox Jonathan CSee Remarks G Gift2019-11-262019-12-051,000— $0450,527SEC↗
Fox Jonathan CSee Remarks S Sale2019-11-252019-11-2710,000$56.52 $565.2K451,527SEC↗
Siu ChristineCFO and Secretary S Sale2019-11-222019-11-229,399$54.71 $514.2K37,071SEC↗
Siu ChristineCFO and Secretary M Exercise2019-11-222019-11-2210,000$0.59 $5.9K46,470SEC↗
Siu ChristineCFO and Secretary S Sale2019-11-222019-11-22601$55.29 $33.2K36,470SEC↗
Siu ChristineCFO and Secretary M Exercise deriv2019-11-212019-11-2210,000— $0182,191SEC↗
Siu ChristineCFO and Secretary M Exercise deriv2019-11-212019-11-2225,000— $0192,191SEC↗
Siu ChristineCFO and Secretary S Sale2019-11-212019-11-22200$56.00 $11.2K36,470SEC↗
Siu ChristineCFO and Secretary S Sale2019-11-212019-11-2224,800$55.12 $1.37M36,670SEC↗
Siu ChristineCFO and Secretary M Exercise2019-11-212019-11-2225,000$0.59 $14.8K61,470SEC↗
Fox Jonathan CSee Remarks S Sale2019-11-212019-11-2210,000$55.11 $551.1K461,527SEC↗
Turtle CameronChief Business Officer S Sale2019-11-202019-11-227,468$55.54 $414.8K87,687SEC↗
Turtle CameronChief Business Officer S Sale2019-11-202019-11-222,532$56.36 $142.7K85,155SEC↗
Fox Jonathan CSee Remarks S Sale2019-11-182019-11-1910,000$50.26 $502.6K471,527SEC↗
Fox Jonathan CSee Remarks S Sale2019-11-152019-11-19900$46.45 $41.8K481,527SEC↗
Fox Jonathan CSee Remarks S Sale2019-11-152019-11-192,000$44.88 $89.8K484,527SEC↗
Fox Jonathan CSee Remarks S Sale2019-11-152019-11-192,100$45.51 $95.6K482,427SEC↗
Fox Jonathan CSee Remarks S Sale2019-10-152019-10-162$36.71 $73486,527SEC↗
Fox Jonathan CSee Remarks S Sale2019-10-152019-10-164,998$36.16 $180.7K486,529SEC↗
Sinha UmaChief Scientific Officer S Sale2019-09-252019-09-272,400$38.38 $92.1K343,681SEC↗
Sinha UmaChief Scientific Officer S Sale2019-09-252019-09-27100$39.15 $3.9K343,581SEC↗
Fox Jonathan CSee Remarks S Sale2019-09-162019-09-185,000$45.74 $228.7K491,527SEC↗
Turtle CameronChief Business Officer S Sale2019-09-042019-09-06643$42.09 $27.1K95,155SEC↗
Turtle CameronChief Business Officer S Sale2019-09-042019-09-064,357$41.51 $180.9K95,798SEC↗
Fox Jonathan CSee Remarks S Sale2019-08-152019-08-192,220$38.36 $85.2K499,307SEC↗
Fox Jonathan CSee Remarks S Sale2019-08-152019-08-192,780$39.01 $108.4K496,527SEC↗
Sinha UmaChief Scientific Officer S Sale2019-07-252019-07-292,967$35.65 $105.8K348,114SEC↗
Sinha UmaChief Scientific Officer S Sale2019-07-252019-07-291,300$36.53 $47.5K346,814SEC↗
Sinha UmaChief Scientific Officer S Sale2019-07-252019-07-29700$37.31 $26.1K346,114SEC↗
Sinha UmaChief Scientific Officer S Sale2019-07-252019-07-2933$38.35 $1.3K346,081SEC↗
Fox Jonathan CSee Remarks S Sale2019-07-152019-07-1715,000$40.04 $600.6K501,527SEC↗
Siu ChristineCFO and Secretary M Exercise deriv2019-07-102019-07-125,000— $0217,191SEC↗
Siu ChristineCFO and Secretary M Exercise2019-07-102019-07-125,000$0.59 $3.0K41,470SEC↗
Siu ChristineCFO and Secretary S Sale2019-07-102019-07-125,000$39.37 $196.8K36,470SEC↗
BridgeBio Pharma, Inc.10% Owner P Buy2019-07-032019-07-08882,353$29.90 $26.38M24,575,501SEC↗
AGUIAR ERICDirector, 10% Owner P Buy2019-07-032019-07-08882,353$29.90 $26.38M24,575,501SEC↗
Satvat Ali J.Director, 10% Owner P Buy2019-07-032019-07-08882,353$29.90 $26.38M24,575,501SEC↗
Kumar NeilChief Executive Officer P Buy2019-07-032019-07-08882,353$29.90 $26.38M24,575,501SEC↗
Siu ChristineCFO and Secretary M Exercise deriv2019-06-262019-06-2817,000— $0222,191SEC↗
Siu ChristineCFO and Secretary M Exercise2019-06-262019-06-2817,000$0.59 $10.0K36,470SEC↗
Lis WilliamDirector A Award deriv2019-06-122019-06-1321,528— $021,528SEC↗
Shah Rajeev M.Director A Award deriv2019-06-122019-06-1321,528— $021,528SEC↗
Satvat Ali J.Director, 10% Owner A Award deriv2019-06-122019-06-1321,528— $021,528SEC↗
AGUIAR ERICDirector, 10% Owner A Award deriv2019-06-122019-06-1321,528— $021,528SEC↗
Siu ChristineCFO and Secretary S Sale2019-06-052019-06-07300$31.03 $9.3K19,470SEC↗
Siu ChristineCFO and Secretary S Sale2019-06-052019-06-0713,421$30.10 $404.0K19,770SEC↗
Siu ChristineCFO and Secretary S Sale2019-06-052019-06-073,279$29.34 $96.2K33,191SEC↗
Turtle CameronChief Business Officer S Sale2019-06-042019-06-066,700$31.33 $209.9K103,455SEC↗
Turtle CameronChief Business Officer S Sale2019-06-042019-06-063,300$32.27 $106.5K100,155SEC↗
Fox Jonathan CSee Remarks A Award2019-05-312019-07-171,769$12.01 $21.2K2,850SEC↗
Sinha UmaChief Scientific Officer A Award2019-05-312019-07-291,769$12.01 $21.2K351,081SEC↗
Turtle CameronChief Business Officer A Award2019-05-312019-06-061,769$12.01 $21.2K110,155SEC↗
Siu ChristineCFO and Secretary A Award2019-05-312019-06-071,769$12.01 $21.2K36,470SEC↗
Fox Jonathan CSee Remarks S Sale2019-05-302019-05-315,000$32.64 $163.2K516,527SEC↗
BridgeBio Pharma, Inc.10% Owner P Buy2019-05-242019-05-291,103,848$25.93 $28.62M23,693,148SEC↗
AGUIAR ERICDirector, 10% Owner P Buy2019-05-242019-05-291,103,848$25.93 $28.62M23,693,148SEC↗
Kumar NeilChief Executive Officer P Buy2019-05-242019-05-291,103,848$25.93 $28.62M23,693,148SEC↗
Satvat Ali J.Director, 10% Owner P Buy2019-05-242019-05-291,103,848$25.93 $28.62M23,693,148SEC↗
Sinha UmaChief Scientific Officer S Sale2019-05-232019-05-28800$27.88 $22.3K349,312SEC↗
Sinha UmaChief Scientific Officer S Sale2019-05-232019-05-284,200$27.16 $114.1K350,112SEC↗
Fox Jonathan CSee Remarks S Sale2019-05-032019-05-065,000$25.03 $125.2K521,527SEC↗
Fox Jonathan CSee Remarks S Sale2019-05-012019-05-031,108$26.01 $28.8K530,419SEC↗
Fox Jonathan CSee Remarks S Sale2019-05-012019-05-033,892$25.30 $98.5K526,527SEC↗
Siu ChristineCFO and Secretary M Exercise deriv2019-04-242019-04-265,000— $0239,191SEC↗
Siu ChristineCFO and Secretary S Sale2019-04-242019-04-265,000$26.11 $130.6K34,701SEC↗
Siu ChristineCFO and Secretary M Exercise2019-04-242019-04-265,000$0.59 $3.0K39,701SEC↗
Fox Jonathan CSee Remarks S Sale2019-04-152019-04-165,000$23.11 $115.5K531,527SEC↗
Siu ChristineCFO and Secretary M Exercise deriv2019-03-192019-03-2110,871— $00SEC↗
Siu ChristineCFO and Secretary M Exercise deriv2019-03-192019-03-2134,662— $0244,191SEC↗
Siu ChristineCFO and Secretary M Exercise2019-03-192019-03-2134,662$0.59 $20.5K46,614SEC↗
Siu ChristineCFO and Secretary S Sale2019-03-192019-03-2111,913$19.66 $234.2K34,701SEC↗
Siu ChristineCFO and Secretary M Exercise2019-03-192019-03-2110,871$0.15 $1.6K11,952SEC↗
BridgeBio Pharma LLC10% Owner S Sale2018-12-102018-12-122,664$13.96 $37.2K22,589,300SEC↗
BridgeBio Pharma LLC10% Owner S Sale2018-12-102018-12-1237,989$13.29 $504.9K22,586,636SEC↗
BridgeBio Pharma LLC10% Owner P Buy2018-12-102018-12-1337,989$13.29 $504.9K22,586,636SEC↗
BridgeBio Pharma LLC10% Owner P Buy2018-12-102018-12-132,664$13.96 $37.2K22,589,300SEC↗
BridgeBio Pharma LLC10% Owner S Sale2018-12-072018-12-1036,314$13.94 $506.2K22,543,787SEC↗
BridgeBio Pharma LLC10% Owner S Sale2018-12-072018-12-104,860$14.36 $69.8K22,548,647SEC↗
BridgeBio Pharma LLC10% Owner P Buy2018-12-072018-12-1336,314$13.94 $506.2K22,543,787SEC↗
BridgeBio Pharma LLC10% Owner P Buy2018-12-072018-12-134,860$14.36 $69.8K22,548,647SEC↗
BridgeBio Pharma LLC10% Owner S Sale2018-12-062018-12-1038,970$13.34 $519.9K22,507,473SEC↗
BridgeBio Pharma LLC10% Owner P Buy2018-12-062018-12-1338,970$13.34 $519.9K22,507,473SEC↗
BridgeBio Pharma LLC10% Owner P Buy2018-12-052018-12-061,103,848$14.01 $15.46M22,468,503SEC↗
Lis WilliamDirector A Award deriv2018-12-042018-12-0743,056— $043,056SEC↗
BridgeBio Pharma LLC10% Owner P Buy2018-12-032018-12-061,750,000$15.50 $27.13M21,364,655SEC↗
Fox Jonathan CSee Remarks A Award2018-11-302019-05-031,081$12.01 $13.0K1,081SEC↗
Sinha UmaChief Scientific Officer A Award2018-11-302019-05-281,081$12.01 $13.0K354,312SEC↗
Turtle CameronChief Business Officer A Award2018-11-302019-06-061,081$12.01 $13.0K108,386SEC↗
Siu ChristineCFO and Secretary A Award2018-11-302019-03-211,081$12.01 $13.0K1,081SEC↗
Sinha UmaChief Scientific Officer A Award deriv2018-11-052018-11-0760,000— $060,000SEC↗
Fox Jonathan CSee Remarks A Award deriv2018-11-052018-11-0770,000— $070,000SEC↗
Siu ChristineSee Remarks A Award deriv2018-11-052018-11-0755,000— $055,000SEC↗
Satvat Ali J.Director, 10% Owner A Award deriv2018-07-012018-07-0343,056— $043,056SEC↗
Shah Rajeev M.Director A Award deriv2018-07-012018-07-0343,056— $043,056SEC↗
AGUIAR ERICDirector A Award deriv2018-07-012018-07-0343,056— $043,056SEC↗
Huh HoyoungDirector A Award deriv2018-06-222018-06-2283,720— $083,750SEC↗
Satvat Ali J.Director, 10% Owner X Exercise deriv2018-06-222018-06-22332,262— $02,909,029SEC↗
Satvat Ali J.Director, 10% Owner X Exercise deriv2018-06-222018-06-22332,262— $00SEC↗
Satvat Ali J.Director, 10% Owner C Conversion deriv2018-06-222018-06-2212,832,123— $00SEC↗
Satvat Ali J.Director, 10% Owner C Conversion deriv2018-06-222018-06-222,909,029— $00SEC↗
Kumar NeilChief Executive Officer C Conversion deriv2018-06-222018-06-2212,832,123— $00SEC↗
Kumar NeilChief Executive Officer X Exercise deriv2018-06-222018-06-22332,262— $00SEC↗
Kumar NeilChief Executive Officer C Conversion deriv2018-06-222018-06-222,909,029— $00SEC↗
Kumar NeilChief Executive Officer X Exercise deriv2018-06-222018-06-22332,262— $02,909,029SEC↗
Shah Rajeev M.Director C Conversion deriv2018-06-222018-06-22922,950— $00SEC↗
RA Capital Healthcare Fund LP10% Owner C Conversion deriv2018-06-222018-06-22922,950— $00SEC↗
BridgeBio Pharma LLC10% Owner X Exercise deriv2018-06-222018-06-26332,262— $00SEC↗
BridgeBio Pharma LLC10% Owner X Exercise deriv2018-06-222018-06-26332,262— $02,909,029SEC↗
BridgeBio Pharma LLC10% Owner C Conversion deriv2018-06-222018-06-262,909,029— $00SEC↗
BridgeBio Pharma LLC10% Owner C Conversion deriv2018-06-222018-06-2612,832,123— $00SEC↗
Satvat Ali J.Director, 10% Owner C Conversion2018-06-222018-06-2218,826,417— $018,826,417SEC↗
Satvat Ali J.Director, 10% Owner F Tax w/h2018-06-222018-06-22211,762$17.00 $3.60M18,614,655SEC↗
Satvat Ali J.Director, 10% Owner P Buy2018-06-222018-06-221,000,000$17.00 $17.00M19,614,655SEC↗
Kumar NeilChief Executive Officer P Buy2018-06-222018-06-221,000,000$17.00 $17.00M19,614,655SEC↗
Kumar NeilChief Executive Officer F Tax w/h2018-06-222018-06-22211,762$17.00 $3.60M18,614,655SEC↗
Kumar NeilChief Executive Officer C Conversion2018-06-222018-06-2218,826,417— $018,826,417SEC↗
Shah Rajeev M.Director C Conversion2018-06-222018-06-221,103,847— $01,103,847SEC↗
Shah Rajeev M.Director P Buy2018-06-222018-06-221,058,824$17.00 $18.00M2,162,671SEC↗
RA Capital Healthcare Fund LP10% Owner C Conversion2018-06-222018-06-221,103,847— $01,103,847SEC↗
RA Capital Healthcare Fund LP10% Owner P Buy2018-06-222018-06-221,058,824$17.00 $18.00M2,162,671SEC↗
BridgeBio Pharma LLC10% Owner P Buy2018-06-222018-06-261,000,000$17.00 $17.00M19,614,655SEC↗
BridgeBio Pharma LLC10% Owner F Tax w/h2018-06-222018-06-26211,762$17.00 $3.60M18,614,655SEC↗
BridgeBio Pharma LLC10% Owner C Conversion2018-06-222018-06-2618,826,417— $018,826,417SEC↗